The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer

被引:126
|
作者
Behrens, P [1 ]
Rothe, M [1 ]
Wellmann, A [1 ]
Krischler, J [1 ]
Wernert, N [1 ]
机构
[1] Univ Bonn, Inst Pathol, D-53105 Bonn, Germany
来源
JOURNAL OF PATHOLOGY | 2001年 / 194卷 / 01期
关键词
breast; carcinoma; pre-invasive; carcinogenesis; stroma induction; Ets-1;
D O I
10.1002/path.844
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The first steps of stroma generation are of pivotal importance for carcinogenesis because at this stage are initiated both angiogenesis, the prerequisite for continuous tumour growth, and the proliferation of stromal fibroblasts, These developments contribute to the onset of tumour invasion by secreting several matrix-degrading proteases, Both angiogenesis and the production of proteases are tightly controlled at several levels; of significant importance is transcription, The Ets-1 transcription factor transactivates several genes encoding matrix-degrading proteases and is thought to be involved in both tumour vascularization and invasion. This study therefore investigated, by in situ hybridization and immunohistochemistry, the expression of Ets-1 and of two of its target genes, encoding matrix metalloproteinase (MMP) 1 and MMP9, in order to demonstrate a topographical in vivo correlation between the expression of these three genes during breast cancer formation. All three genes were first expressed within both endothelial cells and stromal fibroblasts during the onset of stroma generation around intraductal and intralobular in situ carcinomas and they mere significantly up-regulated in the stroma of invasive ductal and lobular canters. The results of this study further support the suggested in vivo role of Ets-1 for both angiogenesis and tumour invasion, via matrix-degrading proteases which are already expressed during the early stages of breast carcinogenesis. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 31 条
  • [31] Hypoxia promotes the expression of Von Willebrand factor in breast cancer cells by up-regulating the transcription factor YY1 and down-regulating the hsa-miR-424
    Tao, Qianying
    Lu, Yuxin
    Qi, Yingxue
    Yu, Die
    Gu, Jiayi
    Zhu, Yifei
    Shi, Chencheng
    Liang, Xin
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 934